CSL Plasma Credit Rating & NNN Cap Rate (2026)

Metric	Details
Entity / Legal Name	CSL Plasma Inc.
Parent Company	CSL Limited (ASX: CSL); collected plasma is used by its CSL Behring business
Credit Ratings (CSL Limited, parent)	S&P: A- / Moody’s: A3 (Stable)
S&P / Moody’s	A- / A3 (Stable)
Investment Grade Status	Parent Rated Investment Grade (CSL Limited); confirm the lease guarantor
Sector	Plasma Collection / Biopharmaceuticals
Collection centers	Close to 350 in the U.S. and Europe (CSL Plasma website, October 2026)
Median asking cap rate	See the live table below
Lease term	Varies; confirm in the lease
Guarantee	Varies; confirm the tenant entity and any guarantor in the lease
Parent Annual Revenue	US$15.8B (CSL Limited total revenue, year ended June 30, 2026)
Building size	Varies; confirm in the property records

CSL Plasma Business Overview & NNN Investment Profile

CSL Plasma Inc. describes itself as one of the world’s largest collectors of human plasma, with close to 350 plasma collection centers in the U.S. and Europe (October 2026). The plasma it collects is used by CSL Behring, the largest business of Australian biotechnology company CSL Limited (ASX: CSL). CSL Behring’s products include immunoglobulins, albumin, hemophilia therapies and hereditary angioedema treatments, and its total revenue was US$11.4 billion for the year ended June 30, 2026. Plasma from the collection network supplies CSL Behring’s manufacturing.

Parent credit: Parent Rated Investment Grade (CSL Limited); confirm the lease guarantor. CSL Plasma’s ultimate parent, CSL Limited, carries long-term ratings of A-/A3 (S&P / Moody’s). That parent credit supports a lease only where CSL Limited or a rated affiliate is the tenant or guarantor, so confirm the guaranty on each property.

The Plasma Collection NNN Investment Case

Plasma collected at CSL Plasma centers is used by CSL Behring to manufacture its therapies, so a center is part of the company’s supply chain rather than only a service location. Review the remaining lease term, how long the center has operated and any competing plasma centers nearby.

In its results for the year ended June 30, 2026, CSL said plasma market fundamentals and demand remain robust and forecast immunoglobulin growth at mid-to-high single digits for fiscal 2027. Company outlooks can change, so weigh the specific center and lease rather than the industry trend alone.

CSL Plasma NNN Lease Structure & Cap Rates

Live asking cap rates for CSL Plasma and comparable tenants:

Tenant	S&P / Moody’s	Median asking cap rate	Middle half of listings	Listings	Median vs. 10-year Treasury
Concentra	BB / n/a	6.57%	6.26% to 6.85%	6	+133 bps

Active listings InvestmentGrade.com tracks with an asking cap rate (stated in the listing, or computed from its stated income and price when no rate is stated), listings last observed October 16, 2026. Asking cap rates are not closed-sale cap rates. The middle half is the range from the 25th to the 75th percentile of listings. The 10-year Treasury yield is 5.24% as of October 1, 2026 (FRED series DGS10). Ratings are the agency ratings in our ratings database for the entity shown, which may be a parent company; the rating type (for example issuer, senior unsecured debt, long-term debt or revenue bond ratings) varies by company and is shown on each tenant page. A rating applies to a lease only if the rated entity signs or guarantees it, so confirm the tenant and any guarantor in the lease. n/a means no verified rating is on file. Not shown because fewer than 3 active listings with a published cap rate were observed: CSL Plasma, BioLife Plasma Services, Grifols.

Initial lease terms, rent increases and building sizes vary by property, so confirm them in the lease and property records.

Comparable NNN Tenants

Comparable Tenant	Rating
BioLife Plasma (Takeda)	BBB+/Baa1
Grifols Plasma	BB-/B1
Concentra	BB

Is CSL Plasma investment grade?

CSL Plasma’s parent company is CSL Limited (CSL Plasma website). CSL Limited carries long-term ratings of A- from S&P and A3 from Moody’s, and a rating at or above BBB‑/Baa3 is investment grade. Whether that credit backs a specific lease depends on the tenant entity and any guaranty named in it.

What asking cap rates are CSL Plasma NNN properties listed at?

Current median asking cap rates for CSL Plasma and comparable tenants are shown in the live table on this page. Pricing for a specific property depends on the remaining lease term, rent level, location and lease guarantor, and asking cap rates are not closed-sale cap rates.

CSL Plasma Net Lease Property: Buying, Selling and Financing

Buying: We find on-market and off-market CSL Plasma properties, review the lease and the tenant’s credit, and compare pricing with current listings. On the majority of transactions, there is no separate fee to you as the buyer; the listing broker pays a cooperating commission.

Selling: We can prepare an opinion of value from current listings and recent sales and, when it fits your goals, run a confidential sale to private investors, family offices and institutional buyers. See our guide to off-market sales.

Financing: Investment Grade Capital, a service of Investment Grade LLC, matches buyers and owners with lenders for acquisitions and refinancing.

1031 exchanges: Tell us your identification and closing deadlines so we can plan the search around them.

Request an NNN investment consultation or email team@investmentgrade.com.

CSL Plasma NNN Properties Observed For Sale

1 active CSL Plasma net lease listing observed across public listing sources, most recently Oct 12, 2026. Asking figures as published by the listing party.

Location	Asking Price	Cap Rate	Building SF	Term Left
Chattanooga, TN	$1,863,800	8.00%	12,744	n/a	View listing

Search all 1 observed CSL Plasma listings and the full NNN inventory

Market observations aggregated from listing broker materials; not offerings by Investment Grade Income Property, LP. Buyer representation available on a cooperating commission basis. Information deemed reliable but not guaranteed.